Johnson & Johnson (NYSE:JNJ), a worldwide leader in multiple myeloma therapies, today announced that the U.S. Food and Drug Administration (FDA) approved TECVAYLI® (teclistamab-cqyv) plus DARZALEX ...

The problem comes down to a key principle in economics, the idea that all resources are scarce. When resources are scarce, people hoard them. A thirsty dog is not getting water if a person is stuck in ...

Canada invites 5,500 candidates through a French-language Express Entry draw with a CRS cut-off of 397, the lowest for the category in over a year ...

After just more than a month of long meetings, sharp disagreements and hard-fought compromises, the Oregon Legislature must ...

Cervical cancer remains a major global health threat to women. According to market research released in 2023, more than 700,000 patients in China were diagnosed, based on histopathological ...

Besieged fertility service Monash IVF has reached a confidential settlement with two families implanted with incorrect ...

RFK Jr's pick for surgeon general promoted in her newsletter companies with allegations of selling unsafe products ...

Basecare Medical (02170.HK) has recently encountered a key catalyst--its Gems one-step embryo culture medium has officially ...

KOMZIFTI™ (ziftomenib) launch generating early revenue momentum and rapid payer coverage decisions – – Market feedback emphasizes differentiated safety, combinability and convenience of ziftomenib, su ...

Federal health data shows Black women are more than three times likely than white women to die around the time of childbirth ...

Researchers developed an mRNA delivery system designed to improve embryo implantation. This approach could enhance ART outcomes and address uterine-factor infertility, with pre-clinical studies ...

The female trailblazers behind Operation Period explain how space discovery can be used to support the next generation of ...